Is serial ultrasound and monitoring necessary for pregnancies with velamentous cord insertion (VCI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serial Ultrasound and Monitoring for Velamentous Cord Insertion

Yes, serial ultrasound surveillance is recommended for pregnancies with velamentous cord insertion (VCI) due to the significantly increased risk of adverse perinatal outcomes including intrauterine fetal demise, fetal growth restriction, and preterm delivery.

Initial Detection and Assessment

VCI should be systematically evaluated at the routine second-trimester anatomy scan (18-22 weeks) using transabdominal ultrasound with color Doppler. 1 The ACR guidelines emphasize that both VCI and vasa previa are more commonly present in multiple gestations and deserve dedicated evaluation at this point in pregnancy, as both conditions are associated with adverse pregnancy outcomes. 1

  • Color Doppler ultrasound has 67% sensitivity and 100% specificity for detecting VCI in the second trimester 2
  • When VCI is identified, transvaginal ultrasound with color Doppler is superior for detecting concurrent vasa previa 2
  • Direct visualization of abnormal cord insertion on routine ultrasound without color Doppler is successful in only approximately 1% of cases 3

Surveillance Protocol

Once VCI is diagnosed, serial surveillance should be performed for the remainder of pregnancy, focusing on fetal growth, amniotic fluid assessment, and umbilical artery Doppler velocimetry. 1

Specific Monitoring Parameters:

  • Fetal biometry every 3-4 weeks to assess for growth restriction, as VCI increases the risk of small for gestational age (SGA) by 1.5-4.3 fold 3, 4, 5
  • Umbilical artery Doppler assessment when growth restriction is suspected or documented 1
  • Amniotic fluid volume assessment at each surveillance visit, as polyhydramnios is associated with VCI 4

Rationale for Serial Monitoring

The evidence strongly supports intensive surveillance based on documented adverse outcomes:

  • Intrauterine fetal demise risk is increased 9-fold (adjusted OR 9.56) in pregnancies with VCI 5
  • Fetal growth restriction occurs 2.3-4.3 times more frequently 3, 4
  • Preterm delivery risk is doubled (OR 2.12-4.6) 3, 4
  • Low Apgar scores are 1.8-2.5 times more common 3
  • Placental abruption risk is increased 8-fold 4

Critical Pitfall to Avoid

Standard nonstress testing (NST) is NOT effective for detecting uteroplacental problems associated with VCI. Only 5% of patients with VCI showed pathologic NST results at prenatal visits, and abnormal umbilical artery Doppler velocimetry was found in none of the examined cases (excluding those with preeclampsia). 3 This means that relying on NST alone will miss the majority of at-risk pregnancies with VCI.

Special Considerations for Multiple Gestations

VCI occurs in up to 22% of monochorionic twins and requires even more intensive surveillance. 1, 2

  • Monochorionic twins with VCI should begin surveillance at 16 weeks with fetal biometry every 2-3 weeks 1
  • VCI in one or both twins increases the risk of twin-twin transfusion syndrome from 7% to 27% 1
  • The presence of VCI with discordant cord insertion sites further increases the risk of growth discordance 1

Delivery Planning

While serial monitoring is essential, the mode of delivery depends on additional risk factors rather than VCI alone. 2 Vaginal delivery is generally preferred for singleton pregnancies with isolated VCI without vasa previa, but cesarean delivery should be strongly considered when VCI is combined with fetal growth restriction and abnormal Doppler findings. 2 For monochorionic twins with VCI and additional complications, elective cesarean delivery should be considered. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Velamentous Umbilical Cord Insertion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Velamentous cord insertion: is it associated with adverse perinatal outcomes?

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.